Recovery from life-threatening transplantation-associated thrombotic microangiopathy using eculizumab in a patient with very severe aplastic anemia
- PMID: 24820211
- DOI: 10.1038/bmt.2014.97
Recovery from life-threatening transplantation-associated thrombotic microangiopathy using eculizumab in a patient with very severe aplastic anemia
Similar articles
-
Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.Front Immunol. 2021 Jan 20;11:564647. doi: 10.3389/fimmu.2020.564647. eCollection 2020. Front Immunol. 2021. PMID: 33552043 Free PMC article.
-
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.Br J Haematol. 2013 Apr;161(2):279-80. doi: 10.1111/bjh.12202. Epub 2013 Jan 7. Br J Haematol. 2013. PMID: 23294015 No abstract available.
-
Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.Bone Marrow Transplant. 2016 Sep;51(9):1241-4. doi: 10.1038/bmt.2016.87. Epub 2016 Apr 11. Bone Marrow Transplant. 2016. PMID: 27064689 No abstract available.
-
Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.Transplantation. 2013 Oct 27;96(8):e58-9. doi: 10.1097/TP.0b013e3182a7fccd. Transplantation. 2013. PMID: 24132114 No abstract available.
-
Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature.Lupus. 2020 May;29(6):631-639. doi: 10.1177/0961203320917460. Epub 2020 Apr 6. Lupus. 2020. PMID: 32252584 No abstract available.
Cited by
-
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Clin Kidney J. 2017 Oct;10(5):600-624. doi: 10.1093/ckj/sfx081. Epub 2017 May 8. Clin Kidney J. 2017. PMID: 28980670 Free PMC article.
-
Transplant-associated Thrombotic Microangiopathy Treated with Eculizumab and Romiplostim.Eur J Case Rep Intern Med. 2021 Feb 10;8(3):002294. doi: 10.12890/2021_002294. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33768076 Free PMC article.
-
Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.Front Immunol. 2021 Jan 20;11:564647. doi: 10.3389/fimmu.2020.564647. eCollection 2020. Front Immunol. 2021. PMID: 33552043 Free PMC article.
-
Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.Pediatr Transplant. 2019 May;23(3):e13381. doi: 10.1111/petr.13381. Epub 2019 Mar 3. Pediatr Transplant. 2019. PMID: 30828947 Free PMC article.
-
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.Blood Adv. 2020 Jun 9;4(11):2536-2547. doi: 10.1182/bloodadvances.2019001242. Blood Adv. 2020. PMID: 32516415 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical